iScience · 2024 · 23 citations · 25 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCancer-associated FibroblastsChemokine NetworksSignal Transduction In CancerTargeted Cancer TherapyTumor Microenvironment ModulationAndrogen Receptor ExpressionAndrogen Receptor RegulationCancer-associated Fibroblast SignalingCancer-associated Fibroblast TargetingPd-l1 BlockadeProgrammed Death-ligand 1 TargetingProstate Cancer Hormonal TherapyProstatic Chemokines
Cancer-associated fibroblasts (CAFs) have been shown to play a key role in prostate cancer treatment resistance, but the role of CAFs in the initial course of enzalutamide therapy for prostate cancer remains unclear. Our research revealed that CAFs secrete CCL5, which promotes the upregulation of androgen receptor (AR) expression in prostate cancer cells, leading to resistance to enzalutamide therapy. Furthermore, CCL5 also enhances the expression of tumor programmed death-ligand 1 (PD-L1), resulting in immune escape. Mechanistically, CCL5 binds to the receptor CCR5 on prostate cancer cells and activates the AKT signaling pathway, leading to the upregulation of AR and PD-L1. The CCR5 antagonist maraviroc to inhibit the CAFs mediated CCL5 signaling pathway can effectively reduce the expression of AR and PD-L1, and improve the efficacy of enzalutamide. This study highlights a promising therapeutic approach targeting the CCL5-CCR5 signaling pathway to improve the effectiveness of enzalutamide.
25
Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.7K citations · Full text
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis, Changxue Lu, Hao Wang et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text
Medicine, Oncology, Pharmacology +17
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas et al. · Cancer Cell · 2017 · 756 citations · Full text
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan, Ya Zhu, Jian Li et al. · Science · 2013 · 716 citations · Full text
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante, Jun‐Li Luo, Sergei I. Grivennikov et al. · Nature · 2010 · 636 citations · Full text
Medicine, Immunology, Oncology +14